Rion Aesthetics is a regenerative medicine company, pioneering the use of platelet exosomes for skin care and restorative clinical applications. Backed by over 15 years of visionary science, we aim to transform skincare through the introduction of ( plated )™ Skin Science, leveraging the power of exosomes to address the most persistent skin challenges. Beyond skincare, Rion Aesthetics is pursuing FDA approval for Regenosomes, the first room-temperature stable off-the-shelf regenerative exosome that drives soft tissue healing, with the ability to address unmet needs in aesthetics medicine for applications in hair loss, regenerative tissue fillers, and topical nano-toxin technology. The company operates in the Biotechnology, Consumer Goods, and Wellness Beauty industries with aspirations of revolutionizing the field of regenerative medicine. Although specific founding date and headquarters details are not available, Rion Aesthetics provides an innovative approach to skincare and clinical applications. Currently, there is no information available on the last investment or the involved investors. Rion Aesthetics appears to have significant potential in the burgeoning field of regenerative medicine and skincare.
There is no investment information
No recent news or press coverage available for Rion Aesthetics.